๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Systemic influence of intravesical chemotherapy with verapamil

โœ Scribed by Simpson, W. G. ;Tseng, M. T. ;Harty, J. I.


Publisher
Springer
Year
1985
Tongue
English
Weight
304 KB
Volume
13
Category
Article
ISSN
0300-5623

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Treatment of superficial bladder cancer
โœ Robert A. Badalament; Riad N. Farah ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 51 KB ๐Ÿ‘ 2 views

Proper care of patients with superficial bladder cancer requires the assessment of multiple factors, including an understanding of the natural history of this disease, accurate clinical staging, and the expected efficacy of each drug. The pharmacology of intravesical mytomycin C is discussed in deta

Advances in the diagnosis and management
โœ Robert A. Badalament; Joseph R. Drago ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 630 KB

Recent advances in the diagnosis and treatment of patients with bladder cancer include flow cytometry , intravesical bacillus Calmette-Guerin (BCG), and systemic chemotherapy. Once the subjects of clinical research protocols, these modalities are currently being incorporated into the general managem

Influence of intravesical administration
โœ Lee, K. ;O'Donnell, R. W. ;Cockett, A. T. K. ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› Springer ๐ŸŒ English โš– 215 KB

The effect of intravesical administration of high dose recombinant tumor necrosis factor-alpha (rTNF) and in combination with systemic recombinant gamma-interferon (rIFN) on murine bladder cancer was studied. RTNF was given at 12.5 micrograms/mouse on days 7, 11 and 15 after tumor instillation or at

Treatment of a primary intracranial germ
โœ Kirshner, Jeffrey J. ;Ginsberg, Sandra J. ;Fitzpatrick, Alicia V. ;Comis, Robert ๐Ÿ“‚ Article ๐Ÿ“… 1981 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 634 KB

## Abstract Primary germ cell neoplasms of the central nervous system (CNS) are rare tumors which generally respond to radiotherapy. Experience is limited in managing the refractory patient. We report a patient whose suprasellar dysgerminoma responded completely to 5,000 rad. Seven years later, dis